These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 30256335)

  • 1. Cervical Cancer Screening Beliefs and Prevalence of LSIL/HSIL Among a University-Based Population in Cameroon.
    Eakin C; Ekollo R; Nembulefack D; Halle-Ekane G; Tangui G; Brady R; Bhattarai B; Orock GE; Greenspan D
    J Low Genit Tract Dis; 2018 Oct; 22(4):274-279. PubMed ID: 30256335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
    Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
    Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the diagnostic value of cervical cytology and HPV HR DNA testing for the diagnosis of low-grade and high-grade squamous intraepithelial lesions across different age groups.
    Paluszkiewicz A; Pruski D; Iwaniec K; Kędzia W
    Ginekol Pol; 2017; 88(3):141-146. PubMed ID: 28397203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing a Fee-for-Service Cervical Cancer Screening and Treatment Program in Cameroon: Challenges and Opportunities.
    DeGregorio G; Manga S; Kiyang E; Manjuh F; Bradford L; Cholli P; Wamai R; Ogembo R; Sando Z; Liu Y; Sheldon LK; Nulah K; Welty T; Welty E; Ogembo JG
    Oncologist; 2017 Jul; 22(7):850-859. PubMed ID: 28536303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
    Sarian LO; Derchain SF; Naud P; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Serpa-Hammes L; Matos J; Gontijo R; Bragança JF; Lima TP; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S; Syrjänen K
    J Med Screen; 2005; 12(3):142-9. PubMed ID: 16156945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.
    Yang J; Nolte FS; Chajewski OS; Lindsey KG; Houser PM; Pellicier J; Wang Q; Ehsani L
    Diagn Cytopathol; 2018 Jan; 46(1):22-27. PubMed ID: 29048733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
    Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
    Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the LC-1000 Flow Cytometry Screening System for Cervical Cancer Screening in Routine Health Checkups.
    Heo I; Kwak HJ; Nah EH; Cho S; Kim S; Cho HI
    Acta Cytol; 2018; 62(4):279-287. PubMed ID: 29843120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development, Implementation, and Evaluation of a Distance Learning and Telementoring Program for Cervical Cancer Prevention in Cameroon.
    Fokom Domgue J; Pande M; Yu R; Manjuh F; Welty E; Welty T; Elit L; Lopez-Varon M; Rodriguez J; Baker E; Dangou JM; Basu P; Plante M; Lecuru F; Randall T; Starr E; Kamgno J; Foxhall L; Waxman A; Hawk E; Schmeler K; Shete S
    JAMA Netw Open; 2022 Nov; 5(11):e2240801. PubMed ID: 36346631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Punch biopsy guided by both colposcopy and HR-HPV status is more efficient for identification of immediate high-grade squamous intraepithelial lesion or worse among HPV-infected women with atypical squamous cells of undetermined significance.
    Ding Z; Li Y; Chen A; Song M; Zhang Y
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():32-36. PubMed ID: 27816739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Papillomavirus Vaccination and Cervical Cytology Outcomes Among Urban Low-Income Minority Females.
    Hofstetter AM; Ompad DC; Stockwell MS; Rosenthal SL; Soren K
    JAMA Pediatr; 2016 May; 170(5):445-52. PubMed ID: 26974250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China.
    Xu H; Lin A; Shao X; Shi W; Zhang Y; Yan W
    Oncotarget; 2016 Dec; 7(50):83775-83783. PubMed ID: 27626178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
    Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
    Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Knowledge, attitudes and practices of health professionals regard to cervical cancer in Cameroon].
    Marie Tebeu P; Saint Saba Antaon J; Adjeba M; Pikop F; Tsuala Fouogue J; Ndom P
    Sante Publique; 2020; 32(5):489-496. PubMed ID: 33723954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of precancerous cervical lesions in women attending Mezam Polyclinic Bamenda, Cameroon.
    Nkfusai NC; Mubah TM; Yankam BM; Tambe TA; Cumber SN
    Pan Afr Med J; 2019; 32():174. PubMed ID: 31303943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating Cervical Cancer Screening with HIV Care in Cameroon: Comparative Risk Analysis of Cervical Disease in HIV-Infected Women Receiving Antiretroviral Therapy to Women in the General Population.
    Bekolo CE; O'Bryan G; Tchago FE; Nangue C; Bekoule PS; Kollo B
    PLoS One; 2016; 11(2):e0149152. PubMed ID: 26866371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does 100% Rapid Review Improve Cervical Cancer Screening?
    Queiroz Filho J; Eleutério J; Ney Cobucci R; de Oliveira Crispim JC; Giraldo PC; Gonçalves AK
    Acta Cytol; 2018; 62(3):209-214. PubMed ID: 29788025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevelance of human papillomavirus (HPV) genotypes detected by PCR in women with normal and abnormal cervico-vaginal cytology.
    Beyazit F; Sılan F; Gencer M; Aydin B; Paksoy B; Unsal MA; Ozdemir O
    Ginekol Pol; 2018; 89(2):62-67. PubMed ID: 29512809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.